Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 2
Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Clinical/translational cancer immunotherapy
Original research
Phase I study of the
177
Lu-DOTA
0
-Tyr
3
-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
Online download statistics by month:
Online download statistics by month: July 2020 to September 2024
Abstract
Full
Pdf
Jul 2020
597
598
182
Aug 2020
235
232
48
Sep 2020
106
106
53
Oct 2020
82
82
30
Nov 2020
53
55
20
Dec 2020
57
57
17
Jan 2021
57
57
21
Feb 2021
57
57
30
Mar 2021
87
87
33
Apr 2021
60
60
28
May 2021
53
53
34
Jun 2021
95
95
43
Jul 2021
90
90
33
Aug 2021
169
169
19
Sep 2021
63
63
25
Oct 2021
72
72
52
Nov 2021
77
77
34
Dec 2021
75
80
37
Jan 2022
74
79
26
Feb 2022
42
42
35
Mar 2022
142
146
38
Apr 2022
71
74
22
May 2022
70
74
35
Jun 2022
68
73
31
Jul 2022
50
53
27
Aug 2022
68
71
27
Sep 2022
75
75
38
Oct 2022
80
85
61
Nov 2022
86
86
25
Dec 2022
47
47
19
Jan 2023
74
74
33
Feb 2023
82
82
26
Mar 2023
92
93
34
Apr 2023
49
51
25
May 2023
65
65
27
Jun 2023
61
61
18
Jul 2023
48
49
26
Aug 2023
57
57
20
Sep 2023
56
56
17
Oct 2023
54
64
15
Nov 2023
69
69
26
Dec 2023
55
55
25
Jan 2024
56
57
30
Feb 2024
64
64
32
Mar 2024
63
64
76
Apr 2024
67
69
42
May 2024
59
60
46
Jun 2024
55
56
46
Jul 2024
88
89
43
Aug 2024
55
55
30
Sep 2024
72
75
41
Total
4299
4360
1801
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?